Achilleas - New Portfolio

Achilleas

Achilleas
Individual Investor
Ranked #402,925 out of 764,637 TipRanks' Investors
Success Rate
35%
48 out of 137
profitable transactions
Average Return
2.50%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 0.71%
6-Month Return▼ 0.92%
12-Month Return▲ 19.24%
YTD Return▼ 3.32%
Total Return▲ 67.17%

Best Trade

Opened at
Closed at
Gain▲ 836.02%

Bio

Amateur trialing for some growth.

Performance

25.72%0-25.72%
▼ 12.40%
▼ 4.03%
▼ 6.36%
Apr 2024
▲ 11.46%
▲ 5.06%
▼ 6.05%
May 2024
▼ 2.25%
▲ 3.53%
▼ 5.60%
Jun 2024
▲ 25.72%
▲ 1.21%
▲ 6.26%
Jul 2024
▼ 4.21%
▲ 2.34%
▼ 0.55%
Aug 2024
▲ 7.82%
▲ 2.10%
▲ 9.38%
Sep 2024
▲ 6.02%
▼ 0.89%
▼ 1.57%
Oct 2024
▼ 2.13%
▲ 0.42%
▲ 0.12%
Nov 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 12.40%▼ 4.03%▼ 6.36%
▲ 11.46%▲ 5.06%▼ 6.05%
▼ 2.25%▲ 3.53%▼ 5.60%
▲ 25.72%▲ 1.21%▲ 6.26%
▼ 4.21%▲ 2.34%▼ 0.55%
▲ 7.82%▲ 2.10%▲ 9.38%
▲ 6.02%▼ 0.89%▼ 1.57%
▼ 2.13%▲ 0.42%▲ 0.12%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
SurgePays
0%
▼ 45.02%
1
Open
Jul 03, 2024
CymaBay Therapeutics
▲ 792.03%
4
Close
Mar 25, 2024
Textainer Group Holdings
▲ 147.10%
2
Close
Mar 14, 2024
Harpoon Therapeutics
▼ 76.42%
2
Close
Mar 08, 2024
Orchard Therapeutics
▼ 68.67%
4
Close
Jan 24, 2024
Kaleyra
▼ 47.89%
3
Close
Oct 04, 2023
Syneos Health
▼ 37.76%
2
Close
Sep 27, 2023
Prometheus Biosciences
▲ 772.63%
2
Close
Jun 15, 2023
Otonomy
▼ 97.36%
2
Close
Apr 11, 2023
ClearSign Combustion
▼ 86.37%
2
Close
Apr 02, 2023
Switch
▲ 104.10%
2
Close
Dec 06, 2022
Epizyme
▼ 90.48%
4
Close
Aug 11, 2022
Arbor Realty
0%
▲ 27.10%
1
Open
Jul 22, 2022
Twilio
0.12%
▼ 0.55%
1
Open
Jul 18, 2022
Exxon Mobil
0.16%
▲ 44.14%
1
Open
Jul 18, 2022
Chevron
0.21%
▲ 19.67%
1
Open
Jul 18, 2022
Zynga
▼ 10.70%
2
Close
May 20, 2022
Take-Two
0%
▲ 41.04%
1
Open
May 20, 2022
Comstock Mining
0.61%
▼ 77.97%
4
Buy
Mar 28, 2022
Gain Therapeutics
0.01%
▼ 72.90%
1
Open
Nov 14, 2021